UK Startup BioOrbit Launches DrugMaking Technology to Space for Cancer Treatment Hot Snakes Media Docuseries Explores Benjaman Kyle Amnesia Case US Futures Slide After Military Action in Strait of Hormuz Jim Cramers Vote of Confidence on Intuit INTU Preceded a Steep Decline IBR vs RAP Choosing the Right Federal Student Loan Repayment Plan SID Q1 2026 Earnings Steep EPS Miss of 185 Amid Cost Pressures iSpecimen Inc ISPC Q3 2024 Earnings Wide EPS Miss Amid Operational Challenges AMPX Q1 2026 Earnings EPS Misses Estimates Amid Strong Stock Rally VICR Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction SAH Q1 2026 Earnings Strong EPS Beat Drives 62 Stock Surge BHRB Stock Slips 109 as Burke Herbert Financial Tests Key Support Levels Arena Group Holdings AREN Shares Edge Higher as Support Level Holds Brookfield Business Partners BBU Slips 2 as Stock Nears Key Support Zone GEN Restaurant Group GENK Slips 234 as Shares Test Key Support Levels Black Hawk Acquisition Corporation Units BKHAU Price Steady at 1190 as SPAC Market Scrutiny Continues Invesco California Value Municipal Income Trust VCV Slight Pullback Within Established Range Mortgage Rate Outlook to 2030 Analysts Weigh In on Where Interest Rates Could Settle TX Q1 2026 Earnings Strong Earnings Beat Despite Revenue Uncertainty Stock Slightly Down Luxury Housing Market Surges While MiddleIncome Buyers Remain on Sidelines UK Regulator Ofcom Says TikTok and YouTube Not Safe Enough for Children Antero Midstream Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Morgan Stanley Direct Lending Fund MSDL Holds Steady Near Resistance Level EOSE Q1 2026 Earnings Narrower Loss Surprises Analysts as Energy Storage Momentum Builds ArcBest Q1 2026 Earnings EPS Surpasses Estimates on Strong Cost Control SCL Q1 2026 Earnings Slight EPS Beat Drives Positive Market Response HIG Q1 2026 Earnings EPS Misses Estimates by 10 Stock Unchanged Amid Mixed Signals CRVL Q1 2026 Earnings EPS of 061 Reported Stock Declines 285 Skye Bioscience Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges CTGO Q1 2026 Earnings Significant EPS Miss Raises Concerns